Featured Research

from universities, journals, and other organizations

Herpes virus exploits immune response to bolster infection

Date:
June 6, 2013
Source:
University of California - San Diego
Summary:
Researchers report that the herpes simplex virus type-1, which affects an estimated 50 to 80 percent of all American adults, exploits an immune system receptor to boost its infectiousness and ability to cause disease.

Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an immune system receptor to boost its infectivity and ability to cause disease.

Related Articles


The findings are published in the June 6, 2013 issue of Nature Communications.

HSV-1 is a persistent and problematic pathogen. Typically, it infects victims through oral secretions (kissing, sharing a contaminated toothbrush) or through openings in the skin. In healthy people, the result may be cold sores or fever blisters. In people with compromised immune systems, HSV-1 can pose more serious and chronic health problems. It can spread, for example, to organs like the brain, lungs and liver, where the infection may become life-threatening. Some patients, such as those with atopic dermatitis -- a common form of eczema that accounts for roughly 20 percent of all dermatologic referrals, are especially vulnerable to serious complications stemming from an HSV-1 infection.

Led by principal investigator Richard L. Gallo, MD, PhD, professor of medicine and chief of UC San Diego's Division of Dermatology, the scientists found that HSV-1 launches an infection by binding to receptors on the surface of skin cells. Ordinarily, if a cell recognizes the virus as an invader, an immune response is immediately triggered, which includes a group of proteins called scavenger receptors that help identify and remove harmful viruses.

But sometimes the process goes awry. While studying HSV-1 and scavenger receptors in cultured human skin cells, Gallo and colleagues in the Atopic Dermatitis Research Network, funded by the National Institute of Allergy and Infectious Diseases, discovered that the virus strongly interacts with a particular receptor called a macrophage receptor with collagenous structure or MARCO, which it uses to gain entry into cells.

In tests comparing mice expressing normal levels of MARCO with mice genetically engineered to lack the receptor, the scientists found that MARCO enhanced the virus' ability to infect cells. Mice lacking the receptor suffered dramatically smaller skin lesions than normal mice with normal levels of MARCO. In a different experiment, the application of chemicals that prevented the virus from binding to MARCO resulted in much-smaller lesions on normal mice.

Gallo said the findings were surprising. "We would have predicted that MARCO would help resist infection," he said, noting it was the first evidence that a scavenger receptor, part of the body's defense system against viral invaders, might actually aid and abet HSV-1 infection.

The research suggests that development of new therapies preventing HSV-1-MARCO interaction may measurably reduce the degree and risk of serious HSV-1-related complications in atopic dermatitis patients and others. The scientists plan to follow up with testing in atopic dermatitis patients, and investigate whether other skin viruses also use the same infection pathway.

Co-authors are Daniel T. MacLeod and Kenshi Yamasaki, Division of Dermatology, Department of Medicine, UCSD; Teruaki Nakatsuji, Division of Dermatology, Department of Medicine, UCSD and Veterans Affairs San Diego Health Care System; and Lester Kobzik, Department of Environmental Health, Harvard School of Public Health

Funding for this research came, in part, from The Atopic Dermatitis Research Network (grant HHSN272201000020C) and National Institutes of Health grants T32 AR062496, R01 A1052453, R01 Ai0833358 and R01 ES110008.


Story Source:

The above story is based on materials provided by University of California - San Diego. The original article was written by Scott LaFee. Note: Materials may be edited for content and length.


Journal Reference:

  1. Daniel T. MacLeod, Teruaki Nakatsuji, Kenshi Yamasaki, Lester Kobzik, Richard L. Gallo. HSV-1 exploits the innate immune scavenger receptor MARCO to enhance epithelial adsorption and infection. Nature Communications, 2013; 4 DOI: 10.1038/ncomms2963

Cite This Page:

University of California - San Diego. "Herpes virus exploits immune response to bolster infection." ScienceDaily. ScienceDaily, 6 June 2013. <www.sciencedaily.com/releases/2013/06/130606141132.htm>.
University of California - San Diego. (2013, June 6). Herpes virus exploits immune response to bolster infection. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2013/06/130606141132.htm
University of California - San Diego. "Herpes virus exploits immune response to bolster infection." ScienceDaily. www.sciencedaily.com/releases/2013/06/130606141132.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins